Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors
In this session, first recorded at the 2022 IO360° Summit, Dr Semenza will talk about how his work is impacting cancer immunotherapy. Dr Semenza’s groundbreaking discovery of hypoxia-inducible factors...
14 Jan 202323min
Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
Neoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds ...
13 Jan 202327min
Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.
Nouhad Husseini, MBA, SVP, Business Development and Corporate Strategy, Regeneron Pharmaceuticals with Allan Shaw, CFO / Founder & Senior Managing Director, Portage Biotech / Shaw Strategic Capital,...
12 Jan 202322min
Panel: Targeted Radiotherapy and the Impact on IO
What is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medic...
11 Jan 202331min
What’s Next on the IO Radar? Top 10 Recommendations from Dr Andrew Baum, Citi
Learn more about the IO360° Summit at www.io360summit.com
10 Jan 202327min
KEYNOTE FIRESIDE CHAT with Dr Robert Langer and Dr Ester Caffarel-Salvador
In this podcast, you will hear a keynote fireside discussion with Dr Robert Langer, MIT, and Dr Ester Caffarel-Salvador, Chiesi USA, from the 2022 PODD Conference regarding current projects in the Lan...
10 Jan 202336min
Panel: Role of China in the BD Process
This panel, first recorded at the 2021 Immuno-Oncology 360° Summit, will bring together chinese biotechs to share how they are partnering with additional IO companies to advance cancer treatments for ...
9 Jan 202331min
Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic
In this session, GSK shares how they delivered on patient and caregiver engagements, especially with communities experiencing the highest COVID burden. They gained insights on study designs, education...
6 Jan 202319min
